EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
Clinical trials for EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS trials appear
Sign up with your email to follow new studies for EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare vasculitis: rituximab may outperform standard therapy
Disease control CompletedThis study tested whether rituximab is better than azathioprine at keeping eosinophilic granulomatosis with polyangiitis (EGPA) in remission. 98 adults with newly-diagnosed or relapsing EGPA who had already achieved remission took part. The goal was to see which drug helped patie…
Matched conditions: EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New study confirms Long-Term safety of NUCALA for rare inflammatory disease
Disease control CompletedThis study looked at the long-term safety and effectiveness of the drug NUCALA in people with a rare disease called EGPA, which causes inflammation in blood vessels. About 300 adults who were already prescribed NUCALA for EGPA were followed for up to 2 years. Researchers tracked …
Matched conditions: EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 19, 2026 11:59 UTC